SI2780003T1 - Treatment of adrenal insufficiency - Google Patents
Treatment of adrenal insufficiencyInfo
- Publication number
- SI2780003T1 SI2780003T1 SI201231759T SI201231759T SI2780003T1 SI 2780003 T1 SI2780003 T1 SI 2780003T1 SI 201231759 T SI201231759 T SI 201231759T SI 201231759 T SI201231759 T SI 201231759T SI 2780003 T1 SI2780003 T1 SI 2780003T1
- Authority
- SI
- Slovenia
- Prior art keywords
- treatment
- adrenal insufficiency
- adrenal
- insufficiency
- Prior art date
Links
- 206010001367 Adrenal insufficiency Diseases 0.000 title 1
- 208000017515 adrenocortical insufficiency Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1119985.8A GB201119985D0 (en) | 2011-11-19 | 2011-11-19 | Treatment of adrenal insufficiency |
| EP12806617.2A EP2780003B1 (en) | 2011-11-19 | 2012-11-19 | Treatment of adrenal insufficiency |
| PCT/GB2012/052864 WO2013072707A1 (en) | 2011-11-19 | 2012-11-19 | Treatment of adrenal insufficiency |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2780003T1 true SI2780003T1 (en) | 2020-07-31 |
Family
ID=45475414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201231759T SI2780003T1 (en) | 2011-11-19 | 2012-11-19 | Treatment of adrenal insufficiency |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US9675559B2 (en) |
| EP (1) | EP2780003B1 (en) |
| JP (2) | JP6228125B2 (en) |
| KR (1) | KR101995999B1 (en) |
| AU (1) | AU2012338583B2 (en) |
| BR (1) | BR112014011745B1 (en) |
| CA (1) | CA2854717C (en) |
| CY (1) | CY1123130T1 (en) |
| DK (1) | DK2780003T3 (en) |
| ES (1) | ES2782503T3 (en) |
| GB (2) | GB201119985D0 (en) |
| HR (1) | HRP20200452T1 (en) |
| HU (1) | HUE048445T2 (en) |
| IL (1) | IL232065A (en) |
| LT (1) | LT2780003T (en) |
| PL (1) | PL2780003T3 (en) |
| PT (1) | PT2780003T (en) |
| RS (1) | RS60132B1 (en) |
| SI (1) | SI2780003T1 (en) |
| SM (1) | SMT202000230T1 (en) |
| WO (1) | WO2013072707A1 (en) |
| ZA (1) | ZA201403462B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201119985D0 (en) | 2011-11-19 | 2012-01-04 | Diurnal Ltd | Treatment of adrenal insufficiency |
| GB201308933D0 (en) * | 2013-05-17 | 2013-07-03 | Diurnal Ltd | Paediatric composition |
| KR102186095B1 (en) | 2018-05-14 | 2020-12-03 | 주식회사 엘지화학 | Compound and organic light emitting device comprising the same |
| US11904046B1 (en) | 2022-11-14 | 2024-02-20 | Eton Pharmaceuticals, Inc. | Hydrocortisone oral liquid formulations |
| WO2025240605A1 (en) | 2024-05-15 | 2025-11-20 | Neurocrine Biosciences, Inc. | Combination treatment |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69101291T2 (en) * | 1990-08-30 | 1994-07-07 | Senju Pharma Co | Composition for the controlled delivery of medicines. |
| DK0876142T3 (en) * | 1996-01-16 | 2001-11-19 | Advanced Polymer Systems Inc | Topical administration of drugs to the lower gastrointestinal tract |
| CN1244119A (en) * | 1997-01-06 | 2000-02-09 | 辉瑞大药厂 | Rapidly releasing and taste-masking pharmaceutical dosage form |
| SE0401031D0 (en) * | 2004-04-22 | 2004-04-22 | Duocort Ab | A new glucocorticoid replacement therapy |
| PL1744760T3 (en) | 2004-04-22 | 2015-04-30 | Acucort Ab | Pharmaceutical compositions for acute glucocorticoid therapy |
| US9050249B2 (en) | 2004-04-30 | 2015-06-09 | Astellas Pharma Inc. | Oral pharmaceutical compositions in timed-release particle form and fast-disintegrating tablets containing this composition |
| WO2006026504A2 (en) | 2004-08-27 | 2006-03-09 | Spherics, Inc. | Mucoadhesive oral formulations of high permeability, high solubility drugs |
| EP2120868A4 (en) | 2007-04-11 | 2010-08-25 | Perrigo Israel Phamaceuticals | Low-dose mometasone formulations |
| JP5461179B2 (en) * | 2007-06-06 | 2014-04-02 | 旭化成ケミカルズ株式会社 | Cellulosic micronucleus particles and method for producing the same |
| GB0817120D0 (en) | 2008-09-19 | 2008-10-29 | Diurnal Ltd | Treatment of adrenal insufficiency |
| US20120183610A1 (en) | 2009-04-07 | 2012-07-19 | Lennernaes Hans | glucocorticoid therapy |
| CN102549029B (en) * | 2009-09-17 | 2015-03-04 | 巴斯夫欧洲公司 | Pellets coated with coatings containing active substances |
| MX337429B (en) | 2010-05-20 | 2016-03-04 | Duocort Pharma Ab | Posology and administration of glucocorticoid based compositions. |
| GB201119985D0 (en) | 2011-11-19 | 2012-01-04 | Diurnal Ltd | Treatment of adrenal insufficiency |
| GB201308933D0 (en) | 2013-05-17 | 2013-07-03 | Diurnal Ltd | Paediatric composition |
-
2011
- 2011-11-19 GB GBGB1119985.8A patent/GB201119985D0/en not_active Ceased
-
2012
- 2012-11-19 LT LTEP12806617.2T patent/LT2780003T/en unknown
- 2012-11-19 AU AU2012338583A patent/AU2012338583B2/en active Active
- 2012-11-19 KR KR1020147015908A patent/KR101995999B1/en active Active
- 2012-11-19 PT PT128066172T patent/PT2780003T/en unknown
- 2012-11-19 PL PL12806617T patent/PL2780003T3/en unknown
- 2012-11-19 SM SM20200230T patent/SMT202000230T1/en unknown
- 2012-11-19 RS RS20200316A patent/RS60132B1/en unknown
- 2012-11-19 HR HRP20200452TT patent/HRP20200452T1/en unknown
- 2012-11-19 JP JP2014541759A patent/JP6228125B2/en active Active
- 2012-11-19 HU HUE12806617A patent/HUE048445T2/en unknown
- 2012-11-19 US US14/354,651 patent/US9675559B2/en active Active
- 2012-11-19 WO PCT/GB2012/052864 patent/WO2013072707A1/en not_active Ceased
- 2012-11-19 SI SI201231759T patent/SI2780003T1/en unknown
- 2012-11-19 DK DK12806617.2T patent/DK2780003T3/en active
- 2012-11-19 GB GB1407380.3A patent/GB2509663B/en active Active
- 2012-11-19 ES ES12806617T patent/ES2782503T3/en active Active
- 2012-11-19 BR BR112014011745-4A patent/BR112014011745B1/en active IP Right Grant
- 2012-11-19 CA CA2854717A patent/CA2854717C/en active Active
- 2012-11-19 EP EP12806617.2A patent/EP2780003B1/en active Active
-
2014
- 2014-04-10 IL IL232065A patent/IL232065A/en active IP Right Grant
- 2014-05-14 ZA ZA2014/03462A patent/ZA201403462B/en unknown
-
2017
- 2017-03-30 US US15/473,724 patent/US9717740B1/en active Active
- 2017-06-22 JP JP2017122497A patent/JP2017200942A/en active Pending
-
2020
- 2020-03-31 CY CY20201100304T patent/CY1123130T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2717855A4 (en) | Methods of treatment | |
| GB201110095D0 (en) | Method of treatment | |
| EP2773754A4 (en) | Method of treatment | |
| IL233111A0 (en) | Treatment of inflammation | |
| GB201106960D0 (en) | Treatment of waste | |
| SG11201400283RA (en) | Treatment of rhinitis | |
| EP2685823A4 (en) | Treatment of cancer | |
| GB201119774D0 (en) | IBS treatment | |
| EP2709665A4 (en) | Treatment of psoriasis | |
| ZA201403462B (en) | Treatment of adrenal insufficiency | |
| ZA201402154B (en) | Treatment of coal | |
| SG2014013585A (en) | Method for bonding of substrates | |
| IL231143A0 (en) | Treatment of rhinitis | |
| GB201121950D0 (en) | Treatment process | |
| EP2791324A4 (en) | Method of treatment | |
| GB201100650D0 (en) | Treatment of adrenal insufficiency | |
| GB201102798D0 (en) | Treatment of adrenal insufficiency | |
| GB201110602D0 (en) | Methods of treatment | |
| GB201109737D0 (en) | Methods of treatment | |
| GB201121044D0 (en) | Treatment of solutions | |
| GB201109266D0 (en) | Method of treatment | |
| GB201109509D0 (en) | Method of treatment | |
| GB201111530D0 (en) | Method of treatment | |
| GB201103044D0 (en) | Method of treatment | |
| GB201100651D0 (en) | Treatment of inflammation |